Introducing the Health2030 Genome Center
EPFL's Geneva outpost, Campus Biotech, where the Health 2030 Genome Center is based. Credit: Alain Herzog, EPFL.
Discover the Health2030 Genome Center at Campus Biotech, "a hub for the development of genomic medicine" in Switzerland.
The Health2030 Genome Center is a multi-institutional hub established to promote genomic medicine in Switzerland. Located at Campus Biotech in Geneva, the Genome Center is the genomic medicine arm of the Health2030 initiative, whose goal is to explore and exploit new technologies in health and personalized medicine. This initiative brings together EPFL and the Universities and University Hospitals of Bern, Geneva, and Lausanne, and is spearheaded by EPFL’s Professor Didier Trono.
Directed by Professor Manolis Dermitzakis at the University of Geneva and co-directed by Professor Jacques Fellay at EPFL's School of Life Sciences, the CHUV and the University of Lausanne, the Health2030 Genome Center is conceived as a hub for genomic activities in Switzerland. It consists in a sequencing platform that performs clinical-grade, high-throughput sequencing for research and clinical services and a data analytics platform that develops large-scale data management and analysis tools. It also hosts a vibrant research community working at the forefront of genomics.